| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VTGN | Vistagen Therapeutics, Inc. | COMMODORE CAPITAL LP | 10% Owner | Aug 07, 2023 | Buy | $23.15 | 775,756 | 17,961,079 | 1,575,000 | Aug 09, 2023, 04:10 PM | |
| VTGN | VistaGen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Dec 30, 2022 | Option Exercise | $0.09 | 5,000 | 438 | 105,111 | Jan 03, 2023, 04:11 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Singh Shawn | CHIEF EXECUTIVE OFFICER | Dec 30, 2022 | Option Exercise | $0.09 | 5,000 | 438 | 158,998 | Jan 03, 2023, 04:10 PM | |
| VTGN | VistaGen Therapeutics, Inc. | GIN JERRY B | Director | Aug 18, 2022 | Buy | $0.18 | 100,000 | 17,870 | 100,000 | Aug 22, 2022, 05:12 PM | |
| VTGN | VistaGen Therapeutics, Inc. | GIN JERRY B | Director | Aug 18, 2022 | Buy | $0.18 | 100,000 | 17,870 | 100,000 | Aug 22, 2022, 05:12 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Adler Reid G. | CHIEF LEGAL OFFICER | Aug 17, 2022 | Buy | $0.17 | 300,000 | 50,910 | 334,629 | Aug 19, 2022, 03:45 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Singh Shawn | CHIEF EXECUTIVE OFFICER | Aug 17, 2022 | Buy | $0.17 | 600,000 | 103,200 | 626,234 | Aug 18, 2022, 03:56 PM | |
| VTGN | VistaGen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Jul 30, 2022 | Option Exercise | $0.75 | 5,000 | 3,740 | 100,111 | Jul 15, 2022, 04:30 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Singh Shawn | CHIEF EXECUTIVE OFFICER | Jun 30, 2022 | Option Exercise | $0.75 | 5,000 | 3,740 | 153,998 | Jul 15, 2022, 04:30 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Smith Mark Alan | CHIEF MEDICAL OFFICER | Jun 30, 2022 | Option Exercise | $0.75 | 5,000 | 3,740 | 19,915 | Jul 15, 2022, 04:30 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Koh Bong Y | 10% Owner | Jul 12, 2022 | Sale | $0.89 | 60,000 | 53,400 | 20,637,286 | Jul 14, 2022, 05:33 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Singh Shawn | CHIEF EXECUTIVE OFFICER | May 12, 2022 | Option Exercise | $1.00 | 100,000 | 100,000 | 148,998 | May 16, 2022, 01:39 PM | |
| VTGN | VistaGen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Jan 11, 2022 | Option Exercise | $1.00 | 18,750 | 18,750 | 94,571 | Jan 12, 2022, 05:21 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Smith Mark Alan | CHIEF MEDICAL OFFICER | Dec 31, 2021 | Option Exercise | $1.66 | 2,655 | 4,401 | 14,915 | Jan 03, 2022, 04:25 PM | |
| VTGN | VistaGen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Dec 31, 2021 | Option Exercise | $1.66 | 3,575 | 5,926 | 75,821 | Jan 03, 2022, 04:20 PM | |
| VTGN | VistaGen Therapeutics, Inc. | SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Dec 31, 2021 | Option Exercise | $1.66 | 3,623 | 6,005 | 64,958 | Jan 03, 2022, 04:19 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Singh Shawn | CHIEF EXECUTIVE OFFICER | Dec 31, 2021 | Option Exercise | $1.66 | 3,623 | 6,005 | 48,998 | Jan 03, 2022, 04:17 PM | |
| VTGN | VistaGen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Sep 07, 2021 | Sale | $3.13 | 30,000 | 93,750 | 72,786 | Sep 08, 2021, 06:58 PM | |
| VTGN | VistaGen Therapeutics, Inc. | SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Aug 17, 2021 | Buy | $2.73 | 3,750 | 10,238 | 34,641 | Aug 18, 2021, 06:20 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Smith Mark Alan | CHIEF MEDICAL OFFICER | Jun 30, 2021 | Option Exercise | $1.95 | 2,260 | 4,399 | 12,260 | Jul 02, 2021, 04:11 PM | |
| VTGN | VistaGen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Jun 30, 2021 | Option Exercise | $0.97 | 92,786 | 90,253 | 102,786 | Jul 02, 2021, 04:10 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Singh Shawn | CHIEF EXECUTIVE OFFICER | Jun 30, 2021 | Option Exercise | $1.95 | 5,000 | 9,732 | 45,375 | Jul 02, 2021, 04:10 PM | |
| VTGN | VistaGen Therapeutics, Inc. | SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Jun 30, 2021 | Option Exercise | $1.95 | 3,391 | 6,601 | 91,115 | Jul 02, 2021, 04:10 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Underdown Brian J. | Director | Mar 19, 2021 | Option Exercise | $1.50 | 2,500 | 3,750 | 2,500 | Mar 22, 2021, 07:06 PM | |
| VTGN | VistaGen Therapeutics, Inc. | SAXE JON S | Director | Mar 19, 2021 | Option Exercise | $1.50 | 2,500 | 3,750 | 5,751 | Mar 22, 2021, 07:03 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Singh Shawn | CHIEF EXECUTIVE OFFICER | Dec 31, 2020 | Option Exercise | $0.45 | 5,000 | 2,261 | 35,375 | Jan 04, 2021, 04:58 PM | |
| VTGN | VistaGen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Dec 31, 2020 | Option Exercise | $0.45 | 5,000 | 2,261 | 10,000 | Jan 04, 2021, 04:57 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Smith Mark Alan | CHIEF MEDICAL OFFICER | Dec 31, 2020 | Option Exercise | $0.45 | 5,000 | 2,261 | 10,000 | Jan 04, 2021, 04:55 PM | |
| VTGN | VistaGen Therapeutics, Inc. | SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Dec 31, 2020 | Option Exercise | $0.45 | 5,000 | 2,261 | 87,724 | Jan 04, 2021, 04:48 PM | |
| VTGN | VistaGen Therapeutics, Inc. | SAXE JON S | Director | Aug 21, 2020 | Buy | $0.69 | 30,000 | 20,700 | 50,000 | Aug 24, 2020, 04:31 PM | |
| VTGN | VistaGen Therapeutics, Inc. | SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Jun 30, 2020 | Option Exercise | $0.45 | 5,000 | 2,240 | 67,724 | Jul 01, 2020, 05:35 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Smith Mark Alan | CHIEF MEDICAL OFFICER | Jun 30, 2020 | Option Exercise | $0.45 | 5,000 | 2,240 | 5,000 | Jul 01, 2020, 05:33 PM | |
| VTGN | VistaGen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Jun 30, 2020 | Option Exercise | $0.45 | 5,000 | 2,240 | 5,000 | Jul 01, 2020, 05:28 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Singh Shawn | CHIEF EXECUTIVE OFFICER | Jun 30, 2020 | Option Exercise | $0.45 | 5,000 | 2,240 | 30,375 | Jul 01, 2020, 05:20 PM | |
| VTGN | VistaGen Therapeutics, Inc. | SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Nov 20, 2019 | Buy | $0.34 | 15,000 | 5,100 | 15,000 | Nov 21, 2019, 07:52 PM | |
| VTGN | VistaGen Therapeutics, Inc. | SAXE JON S | Director | Mar 13, 2019 | Buy | $1.26 | 12,080 | 15,201 | 12,080 | Mar 14, 2019, 05:22 PM | |
| VTGN | VistaGen Therapeutics, Inc. | SAXE JON S | Director | Mar 14, 2019 | Buy | $1.27 | 7,920 | 10,086 | 20,000 | Mar 14, 2019, 05:22 PM | |
| VTGN | VistaGen Therapeutics, Inc. | SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Mar 13, 2019 | Option Exercise | $1.50 | 2,500 | 3,750 | 62,724 | Mar 14, 2019, 05:12 PM | |
| VTGN | VistaGen Therapeutics, Inc. | SAXE JON S | Director | Jan 29, 2019 | Option Exercise | $1.50 | 1,375 | 2,063 | 3,251 | Jan 30, 2019, 04:05 PM | |
| VTGN | VistaGen Therapeutics, Inc. | Singh Shawn | CHIEF EXECUTIVE OFFICER | Jan 14, 2019 | Option Exercise | $1.50 | 25,375 | 38,063 | 25,375 | Jan 15, 2019, 04:29 PM | |
| VSTA | VistaGen Therapeutics, Inc. | Singh Shawn | CHIEF EXECUTIVE OFFICER | Oct 15, 2013 | Option Exercise | $0.64 | 10,000 | 6,400 | 312,174 | Oct 15, 2013, 06:20 PM | |
| VSTA | VistaGen Therapeutics, Inc. | Singh Shawn | CHIEF EXECUTIVE OFFICER | Jun 27, 2013 | Option Exercise | $0.64 | 50,000 | 32,000 | 302,174 | Jun 27, 2013, 03:39 PM | |
| VSTA | VistaGen Therapeutics, Inc. | Singh Shawn | CHIEF EXECUTIVE OFFICER | Dec 06, 2012 | Option Exercise | $0.50 | 100,000 | 50,000 | 252,174 | Dec 06, 2012, 12:58 PM | |
| VSTA | VistaGen Therapeutics, Inc. | Cato Allen Easley | 10% Owner | Dec 15, 2011 | Option Exercise | $9999.44 | 11,363 | 113,623,642 | 28,497 | Jan 09, 2012, 04:50 PM | |
| VSTA | VistaGen Therapeutics, Inc. | CATO HOLDING CO | 10% Owner | Dec 15, 2011 | Option Exercise | $471727.00 | 424,124 | 200,070,742,148 | 3,310,836 | Jan 09, 2012, 01:01 PM | |
| VSTA | VistaGen Therapeutics, Inc. | SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Dec 20, 2011 | Option Exercise | $0.88 | 113,636 | 100,000 | 1,204,468 | Dec 22, 2011, 11:16 AM | |
| VSTA | VistaGen Therapeutics, Inc. | SAXE JON S | Director | Dec 14, 2011 | Option Exercise | $1.25 | 2,784 | 3,480 | 20,138 | Dec 16, 2011, 08:23 PM | |
| EXCA | Excaliber Enterprises, Ltd. | SAXE JON S | Director | May 11, 2011 | Option Exercise | $3.50 | 17,354 | 60,739 | 17,354 | May 25, 2011, 06:57 PM | |
| EXCA | Excaliber Enterprises, Ltd. | RICE A. FRANKLIN | CHIEF FINANCIAL OFFICER | May 11, 2011 | Option Exercise | $3.50 | 229,521 | 803,324 | 229,521 | May 25, 2011, 06:55 PM | |
| EXCA | Excaliber Enterprises, Ltd. | SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | May 11, 2011 | Option Exercise | $3.50 | 545,416 | 1,908,956 | 545,416 | May 25, 2011, 06:53 PM | |
| EXCA | Excaliber Enterprises, Ltd. | Singh Shawn | CHIEF EXECUTIVE OFFICER | May 11, 2011 | Option Exercise | $3.50 | 76,087 | 266,305 | 76,087 | May 25, 2011, 06:52 PM |
Menu